NVO ▲ +0.7% - Novo Nordisk A/S
$NVO Market sources: NOVO NORDISK will collaborate with ANTHROPIC to advance drug R&D.
Novo Nordisk rose 0.7% following news that the company will collaborate with Anthropic to advance its drug research and development efforts, signaling a strategic investment in AI-powered drug discovery capabilities.
16-SEP-2026 08:02 AM ET
Share this post
More filings for $NVO
NVO ▲ +0.4% - Novo Nordisk A/SSep 16, 2026NVO ▼ -1.2% - Novo Nordisk A/SSep 11, 2026NVO ▼ -1.4% - Novo Nordisk A/SSep 11, 2026NVO ▼ -1.9% - Novo Nordisk A/SSep 7, 2026
View full $NVO filing history →💬 Comments
Loading comments…
Leave a comment
